These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27139078)

  • 1. Reacknowledging a "motor dimension" will lead to biologically reliable phenotypes and innovative treatment strategies in mental disorders.
    Hirjak D; Thomann PA; Wolf RC
    Eur Neuropsychopharmacol; 2016 Jul; 26(7):1253-4. PubMed ID: 27139078
    [No Abstract]   [Full Text] [Related]  

  • 2. Pediatric Mental Health Concerns.
    French WP
    Pediatr Ann; 2016 Oct; 45(10):e340-e341. PubMed ID: 27735968
    [No Abstract]   [Full Text] [Related]  

  • 3. A Practical and Holistic Approach to Pediatric Mental Health.
    Hageman JR
    Pediatr Ann; 2016 Oct; 45(10):e336. PubMed ID: 27735966
    [No Abstract]   [Full Text] [Related]  

  • 4. The Promise of Electroencephalography for Advancing Diagnosis and Treatment in Neurodevelopmental Disorders.
    Bowman LC; Varcin KJ
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 Jan; 3(1):7-9. PubMed ID: 29397082
    [No Abstract]   [Full Text] [Related]  

  • 5. Early intervention in neurodevelopmental disorders: underlying neural mechanisms.
    Cioni G; Inguaggiato E; Sgandurra G
    Dev Med Child Neurol; 2016 Mar; 58 Suppl 4():61-6. PubMed ID: 27027609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopmental follow-up for high-risk neonates: current practice in Great Britain.
    Chisholm P; Arasu A; Huertas-Ceballos A;
    Arch Dis Child Fetal Neonatal Ed; 2017 Nov; 102(6):F558-F559. PubMed ID: 28866622
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenotypic features of children with neurodevelopmental diseases in relation to biogenic amines.
    Szymańska K; Kuśmierska K; Nowacka M; Sykut-Cegielska J; Demkow U
    Respir Physiol Neurobiol; 2015 Apr; 209():124-32. PubMed ID: 25514185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol consumption during pregnancy and adverse neurodevelopmental outcomes.
    Vall O; Salat-Batlle J; Garcia-Algar O
    J Epidemiol Community Health; 2015 Oct; 69(10):927-9. PubMed ID: 25903753
    [No Abstract]   [Full Text] [Related]  

  • 9. Infant Motor Delay and Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations in Japan.
    Hatakenaka Y; Kotani H; Yasumitsu-Lovell K; Suzuki K; Fernell E; Gillberg C
    Pediatr Neurol; 2016 Jan; 54():55-63. PubMed ID: 26706480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial strategies for rare neurodevelopmental disorders: challenges and opportunities.
    Krishnan ML; Berry-Kravis E; Capal JK; Carpenter R; Gringras P; Hipp JF; Miller MT; Mingorance A; Philpot BD; Pletcher MT; Rotenberg A; Tjeertes J; Wang PP; Willgoss T; de Wit MC; Jeste SS
    Nat Rev Drug Discov; 2021 Sep; 20(9):653-654. PubMed ID: 34002058
    [No Abstract]   [Full Text] [Related]  

  • 11. Mental Health Issues in Foster Care.
    Lohr WD; Jones VF
    Pediatr Ann; 2016 Oct; 45(10):e342-e348. PubMed ID: 27735969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the Editor-in-Chief's Desk.
    Koplewicz HS
    J Child Adolesc Psychopharmacol; 2017 Sep; 27(7):561. PubMed ID: 28930499
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurobehavioral Disorder Associated with Prenatal Alcohol Exposure (ND-PAE): Proposed DSM-5 Diagnosis.
    Kable JA; O'Connor MJ; Olson HC; Paley B; Mattson SN; Anderson SM; Riley EP
    Child Psychiatry Hum Dev; 2016 Apr; 47(2):335-46. PubMed ID: 26202432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Twenty years of neurodevelopment].
    Mulas F
    Rev Neurol; 2018 Mar; 66(S01):S1-S2. PubMed ID: 29516446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating neurocritical care approaches into neonatology: should all infants be treated equitably?
    Mann PC; Gospe SM; Steinman KJ; Wilfond BS
    J Perinatol; 2015 Dec; 35(12):977-81. PubMed ID: 26248128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric disorders: neurodevelopmental disorders, neurodegenerative disorders, or both?
    Thibaut F
    Dialogues Clin Neurosci; 2018 Dec; 20(4):251-252. PubMed ID: 30936765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerations in biomarker development for neurodevelopmental disorders.
    McPartland JC
    Curr Opin Neurol; 2016 Apr; 29(2):118-22. PubMed ID: 26844621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of dyskinesias with L-dopa infusion in advanced Parkinson's disease.
    Timpka J; Fox T; Fox K; Honig H; Odin P; Martinez-Martin P; Antonini A; Chaudhuri KR
    Acta Neurol Scand; 2016 Jun; 133(6):451-8. PubMed ID: 26358227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary to the in-focus issue "Perinatal brain injury leading to later neurodevelopmental disorders: Early detection and treatment options".
    Tan S; Shi Z
    J Neurosci Res; 2022 Dec; 100(12):2109-2111. PubMed ID: 36177726
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous dopaminergic stimulation reduces risk of motor complications in parkinsonian primates.
    Bibbiani F; Costantini LC; Patel R; Chase TN
    Exp Neurol; 2005 Mar; 192(1):73-8. PubMed ID: 15698620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.